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Cellular senescence is a tumor-suppressive program that involves
chromatin reorganization and speciﬁc changes in gene expression
that trigger an irreversible cell-cycle arrest. Here we combine
quantitative mass spectrometry, ChIP deep-sequencing, and func-
tional studies to determine the role of histone modiﬁcations on
chromatin structure and gene-expression alterations associated
with senescence in primary human cells. We uncover distinct
senescence-associated changes in histone-modiﬁcation patterns
consistent with a repressive chromatin environment and link
the establishment of one of these patterns—loss of H3K4 meth-
ylation—to the retinoblastoma tumor suppressor and the H3K4
demethylases Jarid1a and Jarid1b. Our results show that Jarid1a/
b-mediated H3K4 demethylation contributes to silencing of retino-
blastoma target genes in senescent cells, suggesting a mechanism
by which retinoblastoma triggers gene silencing. Therefore, we
link the Jarid1a and Jarid1b demethylases to a tumor-suppressor
network controlling cellular senescence.
H3K4me3 | histone demethylase
Cellular senescence is an antiproliferative stress-responseprogram that acts as a potent tumor-suppressor mechanism
(1). Senescent cells acquire distinctive features, including a sta-
ble cell-cycle arrest, senescence-associated β-galactosidase (SA-
β-gal) activity, and marked alterations in higher-order chromatin
organization that are associated with dramatic changes in gene
expression (2). In the cancer context, senescence can be trig-
gered by telomere attrition, aberrant proliferative signals, or by
some cytotoxic chemotherapeutic drugs, in each case providing
a barrier to tumor initiation or progression (3). Beyond cancer,
senescent cells can be observed in aged and damaged tissues,
where they contribute to the resolution of some wound-healing
responses (4) and can promote organismal aging (5).
Senescence involves a complex interplay between the p53 and
retinoblastoma (RB) pathways. p53 acts to induce various cell-
cycle inhibitory proteins, whereas RB acts to repress E2F-driven
transcription (6). Although the RB protein family has overlapping
and compensatory functions in cell-cycle control, we have shown
that RB is speciﬁcally required for the repression of E2F target
genes during senescence (7). RB is also required for the formation
of senescence-associated heterochromatic foci (SAHF), potential
centers of gene repression (8). Accordingly, SAHF are enriched in
H3K9me3 (a histone modiﬁcation associated with heterochro-
matin), are devoid of methylated H3K4me3 (a histone modiﬁca-
tion associated with gene activation), and exclude sites of active
transcription (8). Such RB-mediated changes in chromatin mod-
iﬁcations and structure may contribute to its tumor-suppressive
role; however, the underlying mechanisms remain unclear.
To better understand the relationship between chromatin
changes and gene expression during cellular senescence, we took
an unbiased approach to identify global changes in histone
modiﬁcations speciﬁc to senescent cells. Among the changes we
observed, we linked one—loss of H3K4 methylation—to the RB
tumor suppressor and to the RB-binding proteins and H3K4
demethylases Jarid1a and Jarid1b. Our results implicate histone
demethylation as an important regulatory mechanism used by
RB to mediate gene repression in senescent cells.
Results
Senescence-Speciﬁc Loss of H3K4 Methylation.We used quantitative
mass spectrometry (qMS) to characterize the global changes in
histone modiﬁcations occurring during Ras-induced senescence
of IMR90 cells, a well-characterized system where senescence is
enforced by the combined action of the RB and p53 tumor
suppressor pathways (7). Senescence was triggered in these cells
by the activation of ER:H-RasG12V (9) and monitored by the
detection of senescence markers, such as changes in morphology,
increased expression of p16 and p21, silencing of proliferation
genes (e.g., Cyclin A), and an increase in SA-β-gal activity (Fig.
S1 A–C). Histone modiﬁcations were quantiﬁed in growing and
senescent cells using a “one pot” approach, whereby total acid
extracted histones were subjected to qMS (10).
Consistent with heterochromatin formation during senescence
(8), we detected decreased H3K9 acetylation and moderate en-
richment ofH3K9me3 in senescent cells (Fig. S1D andDataset S1).
Senescent cells also displayed a marked increase in the hetero-
chromatic modiﬁcationsH3K27me3 andH4K20me3, a decrease in
several acetylation marks on H3 and H4 (e.g., H3K27ac and
H3K56ac), and a striking loss ofH3K4me2 andH3K4me3 (Fig. 1A
and B, Fig. S1E, and Dataset S1). qMS can also measure combi-
natorial histone modiﬁcation changes, allowing us to detect, for
example, a senescence-associated loss of acetylation in multiple
lysine residues of histone H4 (H4 4ac: K5, K8, K12, and K16) (Fig.
1A, Fig. S1E, and Dataset S1). These changes, which also occurred
in cells triggered to senescence by replicative exhaustion and
treatment with etoposide, were conﬁrmed by immunoblotting with
modiﬁcation-speciﬁc antibodies (Fig. S1 E and F). Collectively,
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these data indicate that the chromatin in senescent cells exists
predominantly in a repressive state.
Because H3K4 methylation is associated with actively tran-
scribed genes, the marked loss of this modiﬁcation in senescent
cells suggested that active histone demethylation might contribute
to gene repression during senescence. Supporting this idea, we
detected a substantial decrease in H3K4me2 and H3K4me3 (Fig.
1 A and B), modiﬁcations associated with actively transcribed
genes, but not changes in H3K4me1 (Fig. 1B), a modiﬁcation that
delineates developmental enhancers (11). The loss of H3K4me3
was conﬁrmed by immunoblotting chromatin from cells triggered
to senesce by oncogenic Ras, etoposide, and replicative exhaus-
tion (Fig. 1C). No consistent changes in H3K4me3 were detected
in quiescent cells (Fig. 1C), indicating that loss of H3K4me3 is
a unique characteristic of senescent cells.
Cell-Cycle Genes Are the Main Targets for the Loss of H3K4me3. To
identify the genomic regions affected by loss of H3K4 methyla-
tion, we performed ChIP using anti-H3K4me3 antibody in
growing, quiescent, and senescent IMR90 cells, followed by deep
sequencing (ChIP-seq). Consistent with previous studies (12), we
detected H3K4me3 at the transcriptional start sites of highly
expressed genes in each IMR90 cell population (Fig. S2A). Be-
cause our qMS analyses detected a global loss of H3K4me3
during senescence, we focused our informatic analyses toward
identifying speciﬁc chromosomal regions affected by changes in
H3K4me3 between growing and senescent cells across each
chromosome (Dataset S2). The number of ChIP-seq reads lo-
cated in each H3K4me3-enriched region in growing or senescent
cells were counted, followed by χ2 analysis to identify regions
that showed signiﬁcantly different read counts between the two
samples. Consistent with our qMS analysis, we observed a sig-
niﬁcant loss of H3K4me3 at many loci in senescent cells com-
pared with growing cells (Fig. 2A and Dataset S3).
The genes that lost H3K4me3 were subjected to Gene On-
tology (GO) analysis to identify the processes they may control,
as well as promoter motif analysis to gain insights into their
regulation. These analyses revealed that genes controlling cell-
cycle progression and DNA replication were enriched among the
set of genes showing loss of H3K4me3 in senescence (Fig. S2B)
(P = 3.0e-30 and 1.0e-13, respectively). Interestingly, genes that
show loss of H3K4me3 frequently contained E2F binding sites in
their promoters, whereas genes that showed either no loss or
gain of H3K4me3 during senescence did not (binomial P value <
2.5e-11) (Fig. S2C). Given that RB binds with higher afﬁnity to
a subset of E2F target genes as cells exit the cycle into senes-
cence (S2D) (7), we examined the overlap between genes bound
by RB and genes that show loss of H3K4me3. Indeed, our ChIP-
Seq data revealed a signiﬁcant correlation (P = 2.6E-16) be-
tween RB binding and H3K4me3 loss during cellular senescence
(Fig. S2E). Thus, RB target genes involved in cell-cycle control
and DNA replication are the most prominent targets for loss of
H3K4me3 during cellular senescence.
RB Is Required for H3K4me3 Demethylation During Senescence. To
test if the loss of H3K4me3 in senescent cells is RB-dependent, we
examined the effect of suppressing RB on the global levels of
H3K4me3 through immunoblotting and ChIP-seq in IMR90 cells
triggered to senesce by oncogenicRas.Wehave previously identiﬁed
shRNAs capable of potently suppressing RB and shown that these
prevent SAHF formation and suppression of a subset of E2F targets
(herein deﬁned as “RB-regulated” genes), but despite an initial
delay, these cells eventually arrest because of a secondary barrier
involving p21 (7). Here, these same RB shRNAs (Fig. S2F) pre-
vented the senescence-associated global loss of H3K4me3 (Fig. 2B).
By further examining H3K4me3 at speciﬁc promoters in grow-
ing, quiescent, and senescent cells, we observed that RB sup-
pression abolished the reduction in H3K4me3 that occurs on RB-
regulated genes in senescent cells (Fig. 2 C and D, and Fig. S2G).
In contrast, the total level of H3K4me3 in quiescent cells remained
unchanged relative to growing cells (Fig. 2B), and only a modest
reduction was observed on the promoters of RB-regulated genes
(Fig. 2C andD). These results further conﬁrm that marked loss of
H3K4me3 is speciﬁc for the senescent state and strongly linkRB to
the regulation of H3K4me3 during cellular senescence.
RB Associates with Jarid1a and Is Required for Jarid1a-Induced
Senescence. Although RB itself does not possess any known his-
tone demethylase activity, it can associate with the Jarid1a and
Jarid1b H3K4me2/3 demethylases (13–15). Like RB, both Jar-
id1a and Jarid1b accumulate in the chromatin fraction during
senescence (Fig. 3A and Fig. S3A), implicating their role in the
removal of H3K4me3. To determine whether RB binds the
Jarid1 proteins in senescent cells, a physiological setting in which
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Fig. 1. Senescence-speciﬁc global loss of H3K4 methylation.
(A) Heatmap representing the relative levels (log2) of the
different histone modiﬁcations in growing (G) vs. senescent (S)
cells. (B) Histograms representing the global percentages of
the different methylation states of H3K4 as determined by
qMS. H3K4un is unmodiﬁed H3K4. The error bars represent
the SD from three technical replicates. (C) Immunoblots using
H3K4 methylation speciﬁc antibodies showing global loss of
H3K4me3 in senescent but not quiescent cells. IMR90 cells
treated with ethanol (lane 1) or with 4OHT for the indicated
time (lanes 2–4), infected with a vector control (lane 5) or
a vector expressing activated Ras (lane 6), treated with DMSO
(lane 7) or 50 μM etoposide (lane 8), growing (lane 9), low
serum quiescence (lane 10), conﬂuency-induced quiescence
(lane 11), and replicative senescence (lane 12). Core histones
were used as a loading control.
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their interaction has not been previously examined, we carried
out reciprocal coimmunopreciptiation experiments on chroma-
tin-enriched fractions using anti-RB and anti-Jarid1a antibodies.
Although this association can be difﬁcult to detect (16), we re-
producibly identiﬁed endogenous Jarid1a protein in RB immu-
noprecipitates from senescent-cell chromatin (Fig. 3B). Although
weak, the signal was speciﬁc (i.e., not observed in IgG immuno-
precipitations) and similar to that observed for the well-estab-
lished RB binding protein, HDAC1 (17). Conversely, we also
detected endogenous RB protein in Jarid1a immunoprecipita-
tions (Fig. S3B). Although detectable in senescent mouse em-
bryo ﬁbroblasts (MEFs) (18), we were unable to detect an
association between RB and endogenous Jarid1b in senescent
IMR90 cells; whether this reﬂects a reagent issue or the lack of
an interaction remains unclear. In addition, suppression of RB
did not prevent chromatin association of the Jarid1 proteins,
implying that Jarid1 targeting to chromatin may not be entirely
RB-dependent or that Jarid1a has RB-independent targets in
senescent cells.
The above data raise the possibility that Jarid1 proteins con-
tribute to senescence by facilitating the silencing of some RB
targets by promoting H3K4 demethylation. Consistent with this
possibility, enforced Jarid1a expression at levels similar to those
observed physiologically during senescence triggered a global
reduction of H3K4me3, which was associated with reduced ex-
pression of key RB , such as MCM3 and Cyclin A (Fig. 3C).
Furthermore, enforced Jarid1a expression triggered cell-cycle
arrest in IMR90 cells (Fig. 3F), which was associated with the
accumulation of senescence markers, such as SA-β-gal and
SAHF (Fig. 3 D and F). Such effects were signiﬁcantly reduced
when using a catalytic inactive mutant of Jarid1a (Fig. 3 E and F)
or a C-terminal deletion that lacks the RB binding domain (Fig.
S3 C–E), implying that both the demethylase activity of Jarid1a
and its ability to bind RB are required for its role in senescence.
To determine whether RB was required for Jarid1a-mediated
repression of key E2F target genes, IMR90 cells expressing either
a control or RB shRNA were transduced with Jarid1a. In cells
with RB knockdown, Jarid1a was unable to repress the E2F target
genes examined (Fig. 4A). Consistent with this ﬁnding, suppres-
sion of RB prevented the accumulation of SAHF and SA-β-gal in
cells expressing Jarid1a (Fig. 4 B and C). However, these cells
eventually underwent cell-cycle arrest (Fig. 4C), likely from the
same p21-dependent proliferation barrier observed in RasV12-
senescent IMR90 cells expressing RB shRNAs (Fig. 4A) (7).
Collectively, these data support a model whereby the association
between RB and Jarid1a can facilitate H3K4 demethylation and
subsequent silencing of E2F targets genes during senescence.
Jarid1 Proteins Act Redundantly to Demethylate H3K4me3 and
Promote Silencing During Senescence. We next assessed whether
the Jarid1 proteins are indeed required for H3K4me3 demethy-
lation during oncogene-induced senescence. We generated mul-
tiple mir-30–based shRNAs targeting either Jarid1a or Jarid1b
and identiﬁed several shRNAs that effectively suppressed their
respective targets (Fig. 5A and Fig. S4A). Suppression of either
Jarid1a or Jarid1b alone in IMR90 cells only partially prevented
the senescence-associated global H3K4me3 demethylation (Fig.
5A and Fig. S4A). Although this partial effect could not be
explained by the ability of the Jarid1 proteins to compensate for
each other at the protein level (Fig. 5B), tandem shRNAs capable
of cosuppressing Jarid1a and Jarid1b cooperated to prevent the
demethylation of H3K4me3, similarly to suppression of RB (Fig.
5B). These data suggest that Jarid1a and Jarid1b play a redundant
role in promoting H3K4 demethylation during senescence.
To evaluate the role of the Jarid1 proteins in the control of RB
target-gene expression in senescent cells, we suppressed Jarid1a,
Jarid1b, or both and quantiﬁed the mRNA levels of known RB
target genes by quantitative RT-PCR (RT-qPCR). This analyses
showed that suppression of either Jarid1a or Jarid1b alone in
senescent cells is insufﬁcient to inﬂuence the expression of most
cell cycle genes tested (e.g., MCM2, MCM3, E2F1), with the ex-
ception of Cyclin A, the expression of which is up-regulated in cells
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expressing shRNA targeting either Jarid1a or Jarid1b (Fig. 5C).
Although the effects were relatively modest, cosuppression of
Jarid1a/b cooperated to prevent the repression of these E2F target
genes (Fig. 5C), indicating that the Jarid1 proteins were collec-
tively required for their proper silencing. Accordingly, ChIP assays
demonstrated that Jarid1a binds to these genes in senescent cells
and that suppression of Jarid1a/b partially inhibits the senescence-
associated demethylation of H3K4me3 (Fig. S4 B and C). These
results are consistent with ChIP-chip data showing that Jarid1a
binds and regulates a subset of E2F targets during differentiation
(19). Although the Jarid1 proteins have been suggested to have
pro-oncogenic functions (20–22), their requirement for E2F tar-
get-gene silencing suggests that the Jarid1 proteins are not simply
a trigger of oncogene induced senescence, but rather participate in
a downstream facet of this program.
To extend this analysis to a genome-wide level, we performed
microarray-based gene-expression proﬁling to identify genes im-
pacted by the Jarid1 proteins in senescent cells. As controls, we
also examined the effect of suppressing Jarid1a, Jarid1b, or both
demethylases on gene expression in growing, quiescent, and
senescent cells [at two time points, postselection (PS) 3 and PS7].
Using a cut-off for signiﬁcance (1.4-fold) based on the qPCR
results above (Fig. 5C), we detected changes in gene expression
between vector control-infected cells and cells expressing either
the single or tandem shRNAs in all three conditions (Dataset S4).
Although growing and quiescent cells showed similar numbers
of up- and down-regulated genes, senescent cells expressing ei-
ther the single or tandem Jarid1 shRNAs showed a clear bias for
up-regulated genes (Dataset S4). Such genes include those that
are incompletely repressed during senescence [e.g., proliferating
cell nuclear antigen (PCNA), Cyclin A], indicating that the Jarid1
proteins contribute to gene repression in the context of senes-
cence. GO analysis showed that although the up-regulated genes
in senescent cells were enriched in cell-cycle genes (P = 8.56E-04
for PS3 with tandem shRNA, P = 1.66E-06 for PS7 with tandem
shRNA, and P= 3.3e-20 for PS3 with Jarid1a shRNA), the genes
up-regulated in growing and quiescent cells showed no enrich-
ment for this group of genes (Dataset S5). In contrast, there was
no speciﬁcity in the ontology categories of down-regulated genes
under any conditions. Taken together, these observations indicate
that the Jarid1 proteins repress expression of a subset of cell-cycle
genes speciﬁcally in senescent cells.
To further test our working model that the Jarid1 proteins
contribute to RB-directed silencing of E2F target genes through
demethylation of H3K4, we integrated our gene-expression pro-
ﬁling datasets with our ChIP-seq datasets for RB and H3K4me3.
As expected, we detected a signiﬁcant overlap (Hyper geometric
test P < 2.2e-29, 68 genes) between those genes that show loss of
H3K4me3 in senescent cells and those that were not effectively
repressed in senescent cells expressing Jarid1a shRNAs. Al-
though the effect was less pronounced, genes up-regulated after
suppression of Jarid1b and suppression of both family members
also showed a correlation with those displaying loss of H3K4me3
[P < 3.3e-3 for shJarid1b (S3), 10 genes, and P < 1.0e-9 for
shTan (S3), 23 genes]. Furthermore, unsupervised hierarchical
clustering of RB-regulated genes (genes repressed by RB in cells
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markers. Values represent the ± SE of at least three independent experiments.
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undergoing senescence) (Dataset S6) indicated that suppression
of Jarid1a, Jarid1b, or both attenuates repression of many of
these genes (Fig. S4D and Dataset S7). Speciﬁcally, we observed
a signiﬁcant overlap (P = 2.7E-9) between RB-regulated genes
and Jarid1a-regulated genes (Fig. 5D) but not between Jarid1a-
regulated genes and p53-regulated (P = 0.052, 2 genes) or NF-
κB-regulated (P = 0.23, 6 genes) genes, two key senescence
regulators for which we also have gene-expression proﬁling data
(23). These data further support a model whereby Jarid1 pro-
teins cooperate with RB to repress E2F target genes by facili-
tating H3K4 demethylation.
Jarid1 Proteins Contribute to Cell-Cycle Arrest During Oncogene-
Induced Senescence. We next examined the effect of suppressing
Jarid1a and Jarid1b on the ability of cells to properly exit the cell
cycle following expression of oncogenic Ras. Previous work
indicates that suppression of RB in cells undergoing senescence
delays the exit from the cell cycle as cells continue to incorporate
BrdU 2–3 d after control cells (7). We therefore measured BrdU
incorporation at PS3, a time point at which control shRNA-
expressing cells have completely exited the cell cycle. Similar to
cells expressing RB shRNAs (7), cells expressing the tandem
shRNA continued to incorporate BrdU at PS3, but cells
expressing shRNA targeting only Jarid1a or Jarid1b showed no
BrdU incorporation, similar to shLuc controls (Fig. 5E). Taken
together our study identiﬁes a crucial role for the speciﬁc loss of
H3K4me3 in establishment of the senescent state. Furthermore,
we provide evidence that this occurs by the coordinated action of
RB and the H3K4 demethylases Jarid1a and Jarid1b.
Discussion
Although senescence is associated with microscopically visible
alterations in chromatin structure, the molecular events leading
to these changes and the factors controlling these molecular
events remain largely uncharacterized. By taking an integrative
approach toward understanding the impact of chromatin changes
in senescence, we demonstrate that senescent cells acquire
a highly repressive chromatin state. We further show that deme-
thylation of H3K4me3 can be directed in part through an RB-
dependent effect of Jarid1 demethylases on a subset of E2F target
promoters. Collectively, our study supports a model where Jarid1a
and Jarid1b contribute to RB-mediated gene repression by pro-
moting H3K4 demethylation on a subset of E2F target genes
during senescence.
Our genome-wide analyses revealed that genes undergoing
H3K4 demethylation during senescence are highly enriched in
E2F target genes. Jarid1a binds to E2F target genes examined
and enforced expression of wild-type Jarid1a, but not a catalyti-
cally inactive mutant, triggers H3K4me3 demethylation and
silences key E2F target genes. Conversely, cosuppression of both
Jarid1a and Jarid1b impairs H3K4 demethylation of some E2F
target genes and blocks the down-regulation of these gene tar-
gets during senescence. Although we cannot exclude the possi-
bility that other H3K4 demethylases play an active role in this
process, our results indicate that the Jarid1 proteins contribute
to the repressive chromatin environment of senescent cells and
provide strong evidence that demethylation of H3K4 contributes
to silencing of E2F target genes as cells exit the cell cycle into
a senescent state.
Our results solidify a link between RB and H3K4 demethy-
lation and thus provide insights into RB action in a context
where it plays a tumor-suppressive role (7). Hence, we observe
that: (i) genes that bind RB and display H3K4 demethylation
during senescence are strongly correlated (P = 2.6E-16); (ii)
endogenous RB associates with the H3K4 demethylase Jarid1a
speciﬁcally in senescent cells; (iii) the RB and the Jarid1 proteins
are required for the repression of an overlapping subset of E2F
target genes; (iv) suppression of RB blocks Jarid1a-induced si-
lencing of E2F target genes; and (v) conversely, a Jarid1a mutant
unable to bind RB is defective at promoting senescence.
The overlap between Jarid1a- and b-regulated genes and those
controlled by RB is signiﬁcant (P = 2.7E-9) and speciﬁc (i.e.,
does not occur with p53- and NF-κB–regulated genes) but is by
no means complete. This ﬁnding is likely because of the fact that
suppression of Jarid1a/b is not as effective as RB knockdown in
preventing the demethylation of H3K4me3 (Fig. 5A) and that
suppression of Jarid1a/b only partially prevents loss of H3K4me3
at E2F target genes (Fig. S4C). In principle, the knockdown of
the Jarid1 proteins might not reduce Jarid1 proteins enough
to prevent their action on some target genes, or there could
be redundancy in promoting gene repression by other H3K4
demethylases. Alternatively, RB could recruit unrelated histone-
modifying enzymes that cooperate with the Jarid1 proteins in the
RB-mediated gene repression. Consistent with this model, we
detect an association between RB and HDAC1 in senescent cells
(Fig. 3B), ﬁnd substantial loss of histone acetylation in senescent
cells (Fig. S1) (8), and see a much larger overlap between genes
that show loss of H3K4me3 and Jarid1a-regulated genes (68
genes, P < 2.2e-29) than we detect for Jarid1-regulated and RB-
target genes. Although multiple mechanisms undoubtedly con-
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Fig. 5. Redundant role for Jarid1 and Jarid1b in the senescence-associated
demethylation of H3K4me3. (A) Immunoblots documenting the effect of
suppressing Jarid1a (1A) or Jarid1b (1B) on the levels of H3K4me3 in sen-
escent cells. Cells expressing RB shRNAs are used as a control. (B) Immuno-
blots from senescent cells expressing the indicated shRNA showing that
cosuppression of Jarid1a and Jarid1b (Tan), like suppression of RB, prevents
the loss of H3K4me3. (C) RT-qPCR analysis documenting the relative ex-
pression of the indicated E2F target genes in senescent cells expressing
shRNAs targeting the Jarid1 proteins. Values represent the ± SE of at least
three independent experiments using two different shRNA for each gene.
(D) Venn diagram illustrating the overlap between RB-regulated and Jarid1a
regulated genes. The list of genes in the overlap is indicated below the Venn
diagram. (E) Histogram documenting BrdU incorporation of cells un-
dergoing senescence at PS3 in the presence of the indicated shRNA. Values
represent the ± SE of at least three independent experiments using two
different shRNA for each gene.
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tribute to RB-mediated gene repression, our results are consis-
tent with a recent RNAi screen performed by Nijwening et al.
that identiﬁed Jarid1b as a gene that, when repressed, can bypass
RB-mediated senescence in MEFs (18). Although neither study
excludes the possibility that the Jarid1 proteins also function
independently of RB, these collective data support a model
whereby the association between RB and Jarid1 proteins can
facilitate H3K4 demethylation and silencing of RB targets genes
during senescence.
The action of Jarid1 proteins during senescence suggests an
antiproliferative or tumor-suppressor role for the Jarid1 pro-
teins. However, recent reports have attributed oncogenic prop-
erties to these factors (16, 20–22). For example, Jarid1a and
Jarid1b have been implicated in the maintenance of a slow-
growing population of cancer cells that are required for contin-
uous tumor growth and that are resistant to cytotoxic and tar-
geted therapy (20, 21), and Jarid1a is required for the tumor
initiation and progression in Rb+/− and Men1-defective mice
(22). In principle, such pro-oncogenic functions may be revealed
by other mutations common to cancer cells; for example, dis-
ruption of tumor-suppressor pathways that are intact in cells
undergoing senescence. In the case of melanomas, which fre-
quently inactivate the RB pathway gene INK4a, or developing
tumors lacking RB, Jarid1 proteins would be unable to cooperate
with RB to facilitate the silencing of E2F-target promoters, en-
abling other normal or aberrant proproliferative functions to
predominate. As such, the biological output of chromatin-mod-
ifying factors in general will be heavily context-dependent, an
important factor to be considered for effective targeting of these
activities as therapeutics in cancer or other diseases.
Materials and Methods
Vectors, Cell Culture, and Gene Transfer. Culture and transduction of IMR90
cells were performed as previously described (8). For information on the
retroviral vectors used, please see SI Materials and Methods.
Senescence Assays and Gene Expression. All of the assays, including detection
of SA-β-gal, BrdU incorporation, detection of SAHF, and measuring gene-
expression changes were done as previously described (8). Isolation of
chromatin-bound proteins was performed as previously described (7) and
subjected to immunoprecipitation with Jarid1a (Cell Signaling) or RB-speciﬁc
(Santa Cruz) antibodies and IgG control. Immunoblotting was carried out as
previously described (8). See SI Materials and Methods for a complete list of
antibodies used.
Gene-expression changes were measured using RT-qPCR as previously
described (7). For the analysis of the expression microarray, the Affymetrix
Human Gene ST 1.0 GeneChip data were preprocessed using Robust Multi-
chip Analysis (RMA) function in Bioconductor. An RMA value of 6 or less
(log2 scale) was considered to be below detection. The probsets with more
than 1.4-fold changes compared with vector control sample were treated as
differentially expressed. The enrichment of GO terms in a particular gene list
was performed using the online tool DAVID (24). P values reported for this
study were corrected using the Benjamini-Hochberg approach (25). Gene-
expression values were clustered and visualized using the Cluster and
TreeView package (26).
Mass Spectrometry. qMS analysis was carried out as previously described (27).
In brief, bulk acid extracted histones were derivatized by treatment with
propionyl anhydride (10). Histones were subsequently labeled with stable
isotope using d10-propionic anhydride (Cambridge Isotope Laboratories).
Online HPLCy separation of peptides was followed by LC–MS/MS using an
LTQ-Orbitrap mass spectrometry (Thermo Fisher Scientiﬁc) as previously de-
scribed (10). All data were manually inspected for quantiﬁcation and MS/MS
interpretation. Three technical replicates were performed for each sample.
ChIP-Seq Analysis. The ChIP experiments were done as previously described
(7). The immunoprecipitated DNA was prepared for Illumina sequencing as
previously described (7). The Solexa sequencing tags were mapped to the
unmasked human reference genome (NCBI v36, hg18) using the Illumina
Eland program. Further details can be found in SI Materials and Methods.
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